Vanguard Group
MTEM

Vanguard Group’s Molecular Templates, Inc. MTEM Stock Holding History

Vanguard Group’s Portfolio MTEM Stock Details MTEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-50,899
Closed -$71.5K – 4387
2024
Q3 		$71.5K Sell
50,899
-9,707
-16% -$13.5K ﹤0.01% 4223
2024
Q2 		$69.7K Sell
60,606
-66,018
-52% -$97.8K ﹤0.01% 4263
2024
Q1 		$284K Buy
126,624
+1,001
+0.8% +$3.37K ﹤0.01% 4119
2023
Q4 		$469K Buy
125,623
+14,967
+14% +$78.3K ﹤0.01% 4050
2023
Q3 		$699K Sell
110,656
-36,668
-25% -$291K ﹤0.01% 3955
2023
Q2 		$1.06M Sell
147,324
-146
-0.1% -$998 ﹤0.01% 3880
2023
Q1 		$840K Hold
147,470
– – ﹤0.01% 3978
2022
Q4 		$726K Sell
147,470
-6,887
-4% -$57K ﹤0.01% 4006
2022
Q3 		$1.74M Sell
154,357
-6,664
-4% -$83.8K ﹤0.01% 3801
2022
Q2 		$2.2M Sell
161,021
-12,784
-7% -$299K ﹤0.01% 3766
2022
Q1 		$8.99M Sell
173,805
-816
-0.5% -$36.1K ﹤0.01% 3207
2021
Q4 		$10.3M Sell
174,621
-8,115
-4% -$608K ﹤0.01% 3187
2021
Q3 		$18.4M Buy
182,736
+3,204
+2% +$330K ﹤0.01% 2911
2021
Q2 		$21.1M Buy
179,532
+7,940
+5% +$1.04M ﹤0.01% 2811
2021
Q1 		$32.5M Buy
171,592
+13,032
+8% +$2.29M ﹤0.01% 2540
2020
Q4 		$22.3M Buy
158,560
+12,658
+9% +$1.87M ﹤0.01% 2584
2020
Q3 		$23.9M Buy
145,902
+44,905
+44% +$7.98M ﹤0.01% 2371
2020
Q2 		$20.9M Buy
100,997
+35,953
+55% +$8.35M ﹤0.01% 2403
2020
Q1 		$13M Buy
65,044
+560
+0.9% +$123K ﹤0.01% 2493
2019
Q4 		$13.5M Buy
64,484
+12,404
+24% +$1.78M ﹤0.01% 2712
2019
Q3 		$5.15M Buy
52,080
+2,688
+5% +$251K ﹤0.01% 3128
2019
Q2 		$6.19M Buy
49,392
+4,647
+10% +$505K ﹤0.01% 3091
2019
Q1 		$3.9M Buy
44,745
+735
+2% +$53.9K ﹤0.01% 3223
2018
Q4 		$2.67M Buy
44,010
+13,602
+45% +$949K ﹤0.01% 3287
2018
Q3 		$2.46M Buy
30,408
+5,208
+21% +$399K ﹤0.01% 3464
2018
Q2 		$1.98M Buy
25,200
+1,383
+6% +$157K ﹤0.01% 3502
2018
Q1 		$2.86M Buy
23,817
+1,052
+5% +$158K ﹤0.01% 3341
2017
Q4 		$3.42M Sell
22,765
-1,747
-7% -$219K ﹤0.01% 3266
2017
Q3 		$2.56M Buy
24,512
+10,451
+74% +$903K ﹤0.01% 3330
2017
Q2 		$912K Sell
14,061
-280
-2% -$22K ﹤0.01% 3587
2017
Q1 		$1.35M Buy
14,341
+1,901
+15% +$178K ﹤0.01% 3504
2016
Q4 		$905K Buy
12,440
+2,079
+20% +$159K ﹤0.01% 3588
2016
Q3 		$1.16M Sell
10,361
-5,987
-37% -$822K ﹤0.01% 3541
2016
Q2 		$1.71M Sell
16,348
-1,054
-6% -$75.4K ﹤0.01% 3424
2016
Q1 		$1.32M Buy
17,402
+2,890
+20% +$171K ﹤0.01% 3515
2015
Q4 		$1.15M Buy
14,512
+1,874
+15% +$924K ﹤0.01% 3574
2015
Q3 		$8.49M Buy
12,638
+1,080
+9% +$768K ﹤0.01% 2689
2015
Q2 		$7.7M Buy
11,558
+785
+7% +$519K ﹤0.01% 2808
2015
Q1 		$7.22M Buy
10,773
+1,492
+16% +$982K ﹤0.01% 2807
2014
Q4 		$4.87M Buy
9,281
+261
+3% +$131K ﹤0.01% 2917
2014
Q3 		$5.37M Buy
9,020
+506
+6% +$350K ﹤0.01% 2786
2014
Q2 		$5.56M Sell
8,514
-319
-4% -$211K ﹤0.01% 2784
2014
Q1 		$6.94M Buy
8,833
+892
+11% +$724K ﹤0.01% 2665
2013
Q4 		$6.12M Buy
7,941
+101
+1% +$76.2K ﹤0.01% 2686
2013
Q3 		$6.01M Buy
7,840
+617
+9% +$507K ﹤0.01% 2640
2013
Q2 		$6.27M Buy
+7,223
New +$6.11M ﹤0.01% 2537

Other funds holding MTEM

Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Vanguard Group's MTEM Position: Q4 2024 in Review

Vanguard Group sold out of Molecular Templates, Inc. (MTEM) in Q4 2024, closing a stake of 50,899 shares — an estimated $71.5K sold.

Vanguard Group first reported a position in MTEM in Q2 2013 and held it in 46 quarters. The position peaked at $32.5M in Q1 2021. 3 funds tracked by Wall St. Rank hold MTEM as of Q4 2024.

  • Vanguard Group reported no remaining Molecular Templates, Inc. position as of Q4 2024 after selling out during the quarter.
  • Vanguard Group sold 50,899 Molecular Templates, Inc. shares in Q4 2024, an estimated $71.5K.
  • Vanguard Group first reported a position in Molecular Templates, Inc. in Q2 2013 and held it in 46 quarters.
  • Vanguard Group's Molecular Templates, Inc. position peaked at $32.5M in Q1 2021.
  • 3 funds tracked by Wall St. Rank held Molecular Templates, Inc. as of Q4 2024.

Based on Vanguard Group's 13F filing for Q4 2024, filed 11 Feb 2025.